Literature DB >> 12119553

Correlation between interleukin 10 and vascular endothelial growth factor expression in human esophageal cancer.

Junko Nagata1, Hiroshi Kijima, Hiroyuki Hatanaka, Tetsuji Tokunaga, Atsushi Takagi, Tetsuya Mine, Hitoshi Yamazaki, Masato Nakamura, Yoshito Ueyama.   

Abstract

Interleukin 10 (IL-10) is an immunosuppressive cytokine produced by T-lymphocytes, and is a regulatory molecule for angiogenesis in various cancers. We examined IL-10 and vascular endothelial growth factor (VEGF) gene expression in 45 esophageal cancer patients who underwent surgical resection. Thirty-seven (82.2%) of the 45 esophageal cancers revealed IL-10 gene expression. VEGF121, VEGF165 and VEGF189 isoforms were detected in 93.3% (42/45), 55.6% (25/45) and 26.7% (12/45) of cases, respectively. IL-10 gene expression was significantly correlated with VEGF121 gene expression (P=0.0039, Fisher's test). The results suggested that IL-10 stimulates angiogenic factor gene expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12119553

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  7 in total

1.  Association of Interleukin-10 (A1082G) gene polymorphism with Oral squamous cell carcinoma in north Indian population.

Authors:  Syed Rizwan Hussain; Mohammad Kaleem Ahmad; Abbas Ali Mahdi; Hena Naqvi; Mohammad Waseem Ahmad; Saurabh Srivastava; Kumud Nigam; Shalini Gupta
Journal:  J Genet       Date:  2016-06       Impact factor: 1.166

2.  Interleukin-10 -1082 promoter polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high-incidence region of north China.

Authors:  Wei Guo; Na Wang; Yi-Min Wang; Yan Li; Deng-Gui Wen; Zhi-Feng Chen; Yu-Tong He; Jian-Hui Zhang
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

3.  Dysregulation of helper T lymphocytes in esophageal squamous cell carcinoma (ESCC) patients is highly associated with aberrant production of miR-21.

Authors:  Hadiseh Samiei; Bizhan Sadighi-Moghaddam; Saeed Mohammadi; Abdolsamad Gharavi; Sara Abdolmaleki; Ayyoob Khosravi; Parviz Kokhaei; Hadi Bazzazi; Ali Memarian
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

Review 4.  Reperfusion of chronic tissue ischemia: nitrite and dipyridamole regulation of innate immune responses.

Authors:  Christopher B Pattillo; Kai Fang; Justin Terracciano; Christopher G Kevil
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

5.  Overexpression and interactions of interleukin-10, transforming growth factor beta, and vascular endothelial growth factor in esophageal squamous cell carcinoma.

Authors:  Mehran Gholamin; Omeed Moaven; Bahram Memar; Moein Farshchian; Hossein Naseh; Reza Malekzadeh; Masoud Sotoudeh; Mohammad Taghi Rajabi-Mashhadi; Mohammad Naser Forghani; Farid Farrokhi; Mohammad Reza Abbaszadegan
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

6.  The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistance.

Authors:  Lara P Fernández; Ruth Sánchez-Martínez; Teodoro Vargas; Jesús Herranz; Roberto Martín-Hernández; Marta Mendiola; David Hardisson; Guillermo Reglero; Jaime Feliu; Andrés Redondo; Ana Ramírez de Molina
Journal:  Sci Rep       Date:  2018-05-31       Impact factor: 4.379

7.  Growth factor restriction impedes progression of wound healing following cataract surgery: identification of VEGF as a putative therapeutic target.

Authors:  Julie A Eldred; Matthew McDonald; Helen S Wilkes; David J Spalton; I Michael Wormstone
Journal:  Sci Rep       Date:  2016-04-14       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.